Osteoprotegerin plasma levels are strongly associated with polymorphisms in human homologue of the mouse progressive ankylosis (ANKH) gene

Annals of Human Genetics

Volumn 71, Issue 3, 2007, Pages 302-307

  Vistoropsky, Y ^a   Malkin, I ^a   Kobyliansky, E ^a   Livshits, Gregory ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

ELISA; Geneticassociation; LD; OPG; SNP; TDT

Indexed keywords

GENE PRODUCT; HUMAN HOMOLOGUE OF THE MOUSE PROGRESSIVE ANKYLOSIS PROTEIN; OSTEOPROTEGERIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MINERALIZATION; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; EVOLUTIONARY HOMOLOGY; EXON; FAMILY STUDY; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC ASSOCIATION; GENETIC REGULATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MALE; NORMAL HUMAN; NUCLEAR FAMILY; NULL HYPOTHESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; SAMPLING; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANIMALS; ANKYLOSIS; BONE REMODELING; ETHNIC GROUPS; FEMALE; HAPLOTYPES; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MIDDLE AGED; OSTEOPROTEGERIN; PHOSPHATE TRANSPORT PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RUSSIA;

EID: 34247148100     PISSN: 00034800     EISSN: 14691809     Source Type: Journal    
DOI: 10.1111/j.1469-1809.2006.00331.x     Document Type: Article

References (22)

1. Abecasis, G. R., Cardon, L. R. & Cookson, W. S. (2000) A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66, 279-292.
2. Arko, B., Prezelj, J., Kocijancic, A., Komel, R. & Marc, J. (2005) Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas 51, 270-279.
3. Benjamini, Y. & Yekutieli, D. (2001) The control of the false discovery rate in multiple testing under dependency. The Annals of Statistics 29, 1165-1188.
4. Choi, J. Y., Shin, A., Park, S. K., Chung, H. W., Cho, S. I., Shin, C. S., Kim, H., Lee, K. M., Lee, K. H., Kang, C., Cho, D. Y. & Kang, D. (2005) Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcif Tissue Int 77, 152-159.
5. Harmey, D., Hessle, L., Narisawa, S., Johnson, K. A., Terkeltaub, R. & Millan, J. L. (2004) Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: An integrated model of the pathogenesis of mineralization disorders. Am J Pathol 164, 1199-209.
6. Horvath, S., Xu., X. & Laird., N. M. (2001) The family based association test method: Strategies for studying general genotype-phenotype associations. Eur J Hum Genet 9, 301-306.
7. Jorgensen, H. L., Kusk, P., Madsen, B., Fenger, M. & Lauritzen, J. B. (2004) Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios. J Bone Miner Metab 22, 132-138.
8. Kanatani, M., Sugimoto, T., Kano, J., Kanzawa, M. & Chihara, K. (2003) Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity. J Cell Physiol 196, 180-189.
9. Kornak, U. & Mundols, S. (2003) Genetic disorders of the skeleton: A developmental approach. Am J Hum Genet 73, 447-474.
10. Kostenuik, P. J. (2005) Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5, 618-625.
11. Licata, A. A. (2005) Discovery, clinical development, and therapeutic uses of bisphosphonates. Ann Pharmacother 39, 668-677.
12. Livshits, G., Pantsulaia, I., Trofimov, S. & Kobyliansky E. (2004) Genetic influences on the circulating cytokines involved in osteoclastogenesis. J Med Genet 41, e76.
13. Malkin, I. & Ginsburg, E. (2003) Program package for Mendelian analysis of pedigree data (MAN, Version 6). Department of Anatomy and Anthropology, Sackler Faculty of Medicine, Tel Aviv University; Technical Report.
14. Malkin, I., Dahm, S., Suk, A., Kobyliansky, E., Toliat, M., Ruf, N., Livshits, G. & Nurnberg, P. (2005) Association of ANKH gene polymorphisms with radiographic hand bone size and geometry in a Chuvasha population. Bone 36, 365-373.
15. Malkin, I., Ermakov, S., Kobyliansky, E. & Livshits, G. (2006) Association between polymorphisms in ANKH locus and skeletal size traits. Hum Genet 120, 42-51.
16. Malkin, I., Ginsburg, E. & Elston, R. C. (2002) Increase in power of transmission-disequilibrium tests for quantitative traits. Genet Epidemiol 23, 234-244.
17. Martin, T. J. (2000) Bisphosphonates-mechanisms of action. Australian Prescriber 23, 130-132.
18. Pan, B., Farrugia, A. N. & To, L. B. (2004) The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 19, 147-154.
19. Trofimov, S., Pantsulaia, I., Kobyliansky, E. & Livshits, G. (2004) Circulating levels of receptor activator of nuclear factor-kappaB ligand/ osteoprotegerin/macrophage-colony stimulating factor in a presumably healthy human population. Eur J Endocrinol 150, 305-311.
20. Van Beek, E. R., Lowik, C. W. & Papapoulos, S. E. (2002) Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: The role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors. Bone 30, 64-70.
21. Yates, A. J., Oreffo, R. O., Mayor, K. & Mundy, G. R. (1991) Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts. J Bone Miner Res 6, 473-478.
22. Zhang, Y., Johnson, K., Russell, R. G., Wordsworth, B. P., Carr, A. J., Terkeltaub, R. A. & Brown M. A. (2005) Association of sporadic chondrocalcinosis with a -4-basepair G-to-A transition in the 5′-untranslated region of ANKH that promotes enhanced expression of ANKH protein and excess generation of extracellular inorganic pyrophosphate. Arthritis Rheum 52, 1110-7.